A Study of Cabergoline for the Treatment of Cocaine Dependence - 1

NCT00033111 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

NIH

Sponsor class

Conditions

Cocaine-Related Disorders
Substance-Related Disorders

Interventions

DRUG: Cabergoline
DRUG: Placebo

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]